Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Healthpoint, DFB to Pay up to $48 Million in Drug Case

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

The Department of Justice (DOJ) announced on Thursday that two privately-held health-care companies will be fined up to nearly $50 million for falsely promoting an unapproved drug as being reimbursable through health care. Healthpoint Ltd. and DFB Pharmaceuticals are to pay up to $48 million, due to fallacious marketing of the prescription bed sore ointment known as Xenaderm.

The initial fine of $28 million will increase by $20 million should there be a change in ownership in either company in the next three years.

The companies claimed that the treatment was reimbursed by Medicaid, although it was not, causing false Medicare and Medicaid claims to pour in. Additionally, the DOJ claims that Xenaderm was not even adequately tested for efficacy and safety, nor did Healthpoint report with fidelity Xenaderm's regulatory status in quarterly reports.

This settlement is the most recent application of the qui tam, or "whistleblower," provision of the False Claims Act, which allows individuals who bring forth evidence of fraud to share in financial settlements with the U.S. government. Since the beginning of 2009, the DOJ has recovered nearly $14 billion through the False Claims Act. Over $10 billion of that amount involves federal health-care fraud.

Healthpoint is an affiliate of DFB Pharmaceuticals. The DOJ notes that, although the fines stand, these are allegations only, and "there has been no determination of liability."

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2143376, ~/Articles/ArticleHandler.aspx, 9/26/2016 8:19:33 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 days ago Sponsored by:
DOW 18,261.45 -131.01 -0.71%
S&P 500 2,164.69 -12.49 -0.57%
NASD 5,305.75 -33.78 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes